Denali Therapeutics Inc.

DNLI · Healthcare

$23.27

Capitalización: 3.72B USDRendimiento por dividendo: —
Advance¿Es buen momento para comprar Denali Therapeutics Inc.? Pregunta a Copenvest AIObtén una lectura Advance con IA sobre timing, riesgo y qué hacen los inversores rastreados.Preguntar a Copenvest AI

Cargando gráfico…

Noticias

Últimos titulares de esta acción

MT Newswires4 sept 2026, 21:12

Denali Therapeutics Insider Sold Shares Worth $261,929, According to a Recent SEC Filing

MT Newswires25 ago 2026, 11:55

B. Riley Adjusts Denali Therapeutics Price Target to $35 From $30, Maintains Buy Rating

Zacks20 ago 2026, 16:20

DNLI Stock Gains 33.1% in Three Months: Buy, Sell or Hold the Stock?

Zacks20 ago 2026, 14:12

Should You Buy, Sell or Hold Biogen Stock After a 9% Rise in a Month?